DIAGENS
Focusing on solving the core technical difficulties in the field of human reproductive health and providing high-tech products and services for clinical hospitals, research institutes and the public.
Launch date
Employees
Market cap
-
Enterprise valuation
€625m (Public information from Dec 2023)
Hangzhou Zhejiang (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Seed | |
* | CNY20.0m | Series A | |
* | N/A | Series A | |
N/A | Series A | ||
* | CNY1.0b | Series B | |
* | N/A | Series C | |
* | CNY100m Valuation: CNY5.0b | Series C | |
* | CNY100m Valuation: CNY5.0b | Series C | |
Total Funding | €153m |